Additionally, insulin resistance, a factor associated with NAFLD, and levels of liver inflammatory cytokines TNF-α and IL-6, were also ameliorated with supplementation of silymarin. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.